| Spearman correlations at 6 month | Mean (SD) scores across levels of disease activity at 6 months | |||||||
---|---|---|---|---|---|---|---|---|---|
 | HAQ-DI | PGA | TJC | SJC | ESR | Low disease activity | Moderate-high | F(1, 331) | P |
 | (n = 378) | (n = 338) | (n = 338) | (n = 338) | (n = 337) | (DAS28 ≤3.2) | disease activity |  |  |
 |  |  |  |  |  | (n = 232) | (n = 101) |  |  |
PF | −0.76 | −0.49 | −0.36 | −0.17 | −0.13 | 73.56 (23.29) | 52.87 (23.51) | 55.18 | <0.001 |
RP | −0.58 | −0.54 | −0.32 | −0.19 | 0.02 | 65.46 (26.24) | 43.19 (24.18) | 53.11 | <0.001 |
BP | −0.64 | −0.65 | −0.44 | −0.29 | −0.09 | 70.86 (18.39) | 47.58 (17.28) | 116.89 | <0.001 |
GH | −0.43 | −0.46 | −0.24 | −0.05 | −0.08 | 63.41 (18.46) | 48.85 (17.85) | 44.60 | <0.001 |
VT | −0.47 | −0.47 | −0.21 | −0.06 | −0.05 | 63.47 (19.10) | 50.19 (18.51) | 34.67 | <0.001 |
SF | −0.51 | −0.45 | −0.24 | −0.10 | −0.01 | 83.73 (20.06) | 69.93 (22.58) | 30.83 | <0.001 |
RE | −0.47 | −0.44 | −0.13 | −0.05 | −0.04 | 75.32 (26.20) | 58.66 (29.20) | 26.52 | <0.001 |
MH | −0.34 | −0.32 | −0.13 | −0.05 | −0.00 | 77.84 (17.99) | 70.00 (20.00) | 12.49 | <0.001 |
PCS | −0.71 | −0.58 | −0.44 | −0.24 | −0.12 | 45.77 (8.40) | 36.48 (7.45) | 91.97 | <0.001 |
MCS | −0.33 | −0.34 | −0.07 | −0.00 | −0.05 | 50.72 (10.51) | 46.16 (12.05) | 12.07 | 0.001 |